IL-2, a master activation factor for helper/regulatory T-cell and natural killer (NK) cell proliferation and differentiation, acting as a mediator for pro- and anti-inflammatory immune responses, is also associated with breast cancer bone metastases. This evidence concerns the gene IL2 and breast carcinoma.